• The monthly packaging world
• /
• s.247
• /
• pp.53-73
• /
• 2013

한국건설생활환경시험연구원은 2012년 2월 15일부터 11월 30일까지 식품의약품안전청에서 시행한 용역연구개발과제의 일환으로 '의료기기 포장 밸리데이션 적용 방안'을 연구했다. 본 고에서는 연구 보고서 내용 중 일부를 소개하도록 한다.

• Journal of Applied Biological Chemistry
• /
• v.65 no.3
• /
• pp.195-202
• /
• 2022

Soybean (Glycine max L.) leaves have been researched as functional food stuff actively, but there is no validation method to control quality of soybean leaves (SL). In this study, we annotated seven kaempferol derivatives to confirm camelliaside A as index metabolite in SL using UHPLC-ESI-TOF-MS. HPLC-UVD validation method of camelliaside A in hot-water extract of SL was established according to validation guideline of functional foods from the Ministry of Food and Safety of Korea. The HPLC-UVD method was validated with reliable parameters for examining specificity, accuracy, precision, limit of detection and quantification and linearity. The established method gave the suitable ranges to qunatitate camelliaside A from the hot-water extract of soybean leaves.

• The monthly packaging world
• /
• s.317
• /
• pp.100-111
• /
• 2019

식품의약품안전처는 가입한 의약품실사상호협력기구(PIC/S)의 규정 변경 사항을 '의약품 제조 및 품질관리에 관한 규정'([별표13])에 반영해 국제 조화하기 위하여 '의약품 제조 및 품질관리에 관한 규정'을 일부개정한다고 밝혔다. 주요 내용은 ▲공정밸리데이션 방법의 선택적 적용, ▲규제의 합리적 개선, ▲포장공정 밸리데이션, 세척 밸리데이션 구체화 등 조문 정비 등이다. 다음에 '의약품 제조 및 품질관리에 관한 규정' 일부개정의 상세한 내용을 살펴보도록 한다.

• The Magazine of the Society of Air-Conditioning and Refrigerating Engineers of Korea
• /
• v.40 no.3
• /
• pp.23-27
• /
• 2011

• Review of Korea Contents Association
• /
• v.14 no.3
• /
• pp.37-42
• /
• 2016

• Korean journal of applied entomology
• /
• v.60 no.3
• /
• pp.263-268
• /
• 2021

The venom of honeybees (Apis mellifera L.) is used to treat many diseases because of its anti-inflammatory and analgesic effects. Bee venom consists of several biologically active molecules and exhibits remarkable anti-cancer effects. However, biological amines, which exhibit diverse functionality such as anti-inflammatory and antibacterial effects, have not been previously reported in bee venom. In this study, we determined the content of putrescine in bee venom by using ultra-performance liquid chromatography. The specificity, accuracy, and precision of the assay were assessed, and the assay validated. The linearity of the putrescine assay was r ≥ 0.99, indicating a moderate level of putrescine in the bee venom. The limit of detection and limit of quantification were both 0.9 ㎍/mL, while the rate of recovery was 96.4%-99.9%. The relative standard deviation (RSD) of the intra-day precision and inter-day precision of the putrescine assay were 0.16% - 0.23% and 0.09% - 0.36%, respectively, with the RSD ≤ 5% indicating excellent precision. Thus, the linearity, limit of detection, limit of quantification, and recovery rate of the putrescine assay were satisfactory. The analysis of the bee venom showed that the putrescine content was 3.1 ± 0.09 mg/g. This study provides fundamental data on putrescine content in bee venom, which will prove useful in further studies of its bioactivity.

• Review of Korea Contents Association
• /
• v.13 no.3
• /
• pp.46-51
• /
• 2015

• Journal of the Korea Academia-Industrial cooperation Society
• /
• v.15 no.1
• /
• pp.396-401
• /
• 2014

In this study, we used NIR spectrum method instead of conventional HPLC method to shorten the analysis and manufacturing time of the loxoprofen products. Loxoprofen mixtures with other pharmaceutical additives were prepared and evaluated by the NIR spectrometer and the HPLC system. Validation of both methods was performed for specificity, accuracy and precision. NIR spectrometer method was validated and revealed proper results for the in-process quality control in the pharmaceutical field. In conclusion, NIR spectrometry can be replaced by HPLC method.

• Proceedings of the Korean Institute of Information and Commucation Sciences Conference
• /
• 2012.10a
• /
• pp.495-497
• /
• 2012

Development of application risk management for medical device software test. First, Through questionnaires, Medical device manufacturers, Analysis of software validation and risk management status. Second, Analyzed by comparing the difference between black box testing and white box testing. Third, After analyzing the potential for software analysis tools using code derived factors were quantified, Finally, Medical device risk management process so that it can be applied to build the framework by FMEA(Failure Mode and Effect Analysis) technique. Through this Difficult to build software validation and risk management processes for manufacturers to take advantage of support in medical device GMP(Good Manufacture Practice).

• Journal of the Korea Institute of Military Science and Technology
• /
• v.13 no.3
• /
• pp.478-485
• /
• 2010

The vaccine is biological pretreatment that improves immunity to a particular disease. We can get immunity from producing antibody with injection antigen which has ability to defense against the disease. The ELISA is the most widely used method to measure antibody titer. We have developed and performed validation of ELISA according to the guideline of KFDA and ICH. In this paper, we have verified ELISA method is an excellent method to measure the titer of anti-PA antibody. We have constructed recombinant protective antigen among anthrax toxins and used as antigen of ELISA. In this validation, we have evaluated precision (repeatability, interlaboratory precision), specificity, linearity(range) and LOD, which are validation articles suggested by guideline. Inter-person precision was replaced with inter-laboratory precision. From the results, we have confirmed high precision in all experiments with CV under 20%.